HIGHLIGHTS
- who: Nikolai A. Lomov et al. from the Department of Molecular Biology, Faculty of Biology, Lomonosov Moscow State University, Moscow, Russia have published the paper: Recurrent Translocations in Topoisomerase Inhibitor-Related Leukemia Are Determined by the Features of DNA Breaks Rather Than by the Proximity of the Translocating Genes, in the Journal: (JOURNAL) of 25/06/2022
SUMMARY
Published maps and institutional affil- Targeting topoisomerase II is an effective treatment approach in cancer chemotherapy. DNA topoisomerase II (TopoII) plays a critical role in replication and transcription, where it resolves DNA catenanes and relieves . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.